NEW YORK, April 6 Reportlinker.com announces that a new market research report is available in its catalogue:
Menarini: PharmaVitae Profile
Advertisement
http://www.reportlinker.com/p0186214/Menarini-PharmaVitae-Profile.html
Introduction
This analysis examines the historical and forecast performance for Menarini in the prescription pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
Advertisement
Reasons to Purchase
*Benchmark Menarini's performance against key rivals in the prescription pharmaceutical sector
*Discover how the company's business model continues to drive sales growth across the established and emerging European markets
*Assess Menarini's position in the hypertension market and the various challenges that its broad antihypertensive portfolio could face
ABOUT DATAMONITOR HEALTHCARE 2
About the PharmaVitae team 2
Chapter 1 About this profile 3
PharmaVitae Explorer database 3
Chapter structure 3
Executive summary 3
Quarterly update 3
Company introduction 3
Company sales 4
Company financials 4
Key products 4
Data sourcing 4
Sales data 4
Analyst consensus 4
Chapter 2 Executive summary 5
Key findings 5
Prescription pharmaceutical sales and growth rate performance, 2003-15 6
Menarini: PharmaVitae forecasts at a glance 7
Strategic insight 8
Robust strategic focus helps drive growth 8
Antihypertensive proposition set to drive an otherwise diverse therapeutic focus 11
SWOT analysis 13
TABLE OF CONTENTS 13
Table of figures 15
Chapter 3 Quarterly news update 16
Latest prescription pharma product news 16
Q1 2010 16
Q4 2009 16
Q3 2009 16
Latest corporate news 17
Q1 2010 17
Q4 2009 17
Q3 2009 17
Chapter 4 Company introduction 18
Key findings 18
Background 19
Key corporate developments 19
M&A history 19
Chapter 5 Company sales 21
Key findings 21
Prescription pharmaceutical sales and growth rate analysis, 2003-15 22
Product analysis 23
Product analysis, 2003-09 24
Product analysis, 2009-15 26
Therapy area analysis 29
Geographic analysis 31
Launch/core/expiry analysis 33
Explanation of launch/core/expiry analysis 33
Launch analysis, 2009-15 34
Core analysis, 2009-15 35
Expiry analysis, 2009-15 36
Launch/core/expiry configuration, 2009-15 37
Molecule type analysis 38
Externalization analysis 39
Chapter 6 Appendix 41
References 41
Abbreviations 41
Exchange rates 43
About Datamonitor 44
About Datamonitor Healthcare 44
Datamonitor consulting 44
Disclaimer 46
List of Tables
Table 1: Menarini - PharmaVitae forecasts at a glance 7
Table 2: Menarini's antihypertensive portfolio 11
Table 3: Menarini product portfolio overview ($m), 2003-09 24
Table 4: Menarini product portfolio overview ($m), 2009-15 26
Table 5: Menarini prescription pharmaceutical sales by therapy area ($m), 2009-15 30
Table 6: Menarini prescription pharmaceutical sales by geographic region ($m), 2009-15 32
Table 7: Menarini launch portfolio overview ($m), 2009-15 34
Table 8: Menarini core portfolio overview ($m), 2009-15 35
Table 9: Menarini expiry portfolio overview ($m), 2009-15 36
Table 10: Menarini prescription pharmaceutical sales by source ($m), 2009-15 40
Table 11: Exchange rates, 2010 43
List of Figures
Figure 1: The PharmaVitae Explorer 3
Figure 2: Menarini prescription pharmaceutical performance, sales ($m) and growth rate (%), 2003-15 6
Figure 3: Menarini's geographical focus, 2003-09, sales ($m) 8
Figure 4: Menarini's externalization focus, 2003-09, sales ($m) 9
Figure 5: Top ten companies in Italy by sales ($m), 2009 10
Figure 6: Antihypertensive product sales ($m), 2003-15 12
Figure 7: Menarini SWOT analysis 13
Figure 8: Menarini prescription pharmaceutical performance, sales ($m) and growth rate (%), 2003-15 22
Figure 9: Menarini Key product sales ($m), 2003-15 23
Figure 10: Menarini key sales growth drivers and resistors ($m), 2003-09 25
Figure 11: Menarini key sales growth drivers and resistors ($m), 2009-15 28
Figure 12: Menarini prescription pharmaceutical sales by therapy area ($m), 2003-15 29
Figure 13: Menarini prescription pharmaceutical sales by geographic region ($m), 2003-15 31
Figure 14: Menarini launch/core/expiry configuration ($m), 2009-15 37
Figure 15: Menarini prescription pharmaceutical sales by molecule type ($m), 2003-15 38
Figure 16: Menarini prescription pharmaceutical sales by source ($m), 2003-15 39
To order this report:
Pharmaceutical Industry: Menarini: PharmaVitae Profile
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
Contact: Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
